Evidence map›Paper›PMID 18224269›Full record

Trial reportOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA2008

The remodeling transient and the calcium economy.

J F Aloia, S Arunabh-Talwar, S Pollack, J K Yeh

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Palopegteriparatide for adults with chronic hypoparathyroidism: skeletal dynamics through 3 years of the phase 2 PaTH forward trial.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2026
    Trial
  3. Trial
  4. Three doses of vitamin D, bone mineral density, and geometry in older women during modest weight control in a 1-year randomized controlled trial.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2017
    Trial
  5. Review
  6. Article
  7. Article
  8. Article
  9. Pitfalls in interpreting interventional studies for osteoporosis.Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

J F AloiaBone Mineral Research Center, Winthrop University Hospital, Mineola, NY, USA. jaloia@winthrop.org
S Arunabh-Talwar
S Pollack
J K Yeh
Winthrop-University Hospital · US

Funding

VITAMIN D SUPPLEMENTATION IN POSTMENOPAUSAL WOMENR01AG015325 · NIA · WINTHROP-UNIVERSITY HOSPITAL · PI ALOIA, JOHN F. · 1998 to 2002
$666k
NIA NIH HHS R01 AG015325NIA NIH HHS R01 AG15325
6 · The paper itself

Abstract

unlabelledThe remodeling transient describes a change in bone mass that lasts one remodeling cycle following an intervention that disturbs the calcium economy. We demonstrated the transient in a study of the response of bone density to calcium/vitamin D3 supplementation and show the hazards of misinterpretation if the transient is not considered.

introductionThe remodeling transient describes a change in bone mass that lasts for one remodeling cycle following an intervention that disturbs the calcium economy.

methodsWe report an intervention with calcium and vitamin D supplementation in 208 postmenopausal African-American women where the remodeling transient was considered a priori in the study design. Both groups (calcium alone vs. calcium + 20 microg (800 IU) vitamin D3) were ensured a calcium intake in excess of 1200 mg/day.

resultsThere were no differences between the two groups in changes in BMD over time. These BMD changes were therefore interpreted to reflect increased calcium intake in both groups but not any influence of vitamin D. A transient increase in bone mineral density was observed during the first year of study, followed by a decline. The remodeling period was estimated at about 9 months, which is similar to histomorphometric estimates.

conclusionIt is problematic to draw conclusions concerning interventions that influence the calcium economy without considering the remodeling transient in study design. Studies of agents that effect bone remodeling must be carried out for at least two remodeling cycles and appropriate techniques must be used in data analysis.

Indexed as

Absorptiometry, PhotonAgedBiomarkersBlack or African AmericanBone DensityBone Density Conservation AgentsBone RemodelingCalciumCholecalciferolCollagen Type IFemaleFemurHumansMiddle AgedOsteocalcinOsteoporosis, PostmenopausalBiomarkersBone Density Conservation AgentsCalciumCholecalciferolCollagen Type Icollagen type I trimeric cross-linked peptideOsteocalcinParathyroid HormonePeptides

Identifiers

PMID18224269
PMCPMC2777650
OpenAlexW2043509347

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.